Juriste - Of Counsel
International tax law
Mergers and acquisitions
Prior to joining Solvaction, Helen was a partner of Deloitte and led Deloitte’s Life Sciences industry practice in Australia for 5 years, having had many years’ experience in the Life Sciences and Health Care industry.
She also specialised in Funds Management, servicing some of the largest funds in the Funds Management industry and has assisted in setting up a number of large international funds, as well as advised on a number of significant M&A deals.
Helen provided strategic tax advice to publicly listed and large multinational companies and is experienced with capital raisings, licensing deals, demergers, implementing offshore structures, intellectual property management and location, and supply chain management.
Helen holds a Bachelor of Laws and a Bachelor of Science from the University of Melbourne and a Master degree on International Taxation.
She is the CEO of Bio Capital Impact Fund and non-executive director of Sienna Cancer Diagnostics.